Positive Action provides funding to community-led and community-based organisations that are committed to eliminating AIDS and supporting people living with HIV.
Through its Community Strategic Initiatives, Positive Action provides funding to community-led and community-based organisations that are committed to eliminating AIDS and supporting people living with HIV. We currently offer funding under two funding streams, Innovator Funding, that aims to test and pilot new ways of working, and Momentum Funding, that aims to scale-up proven ways of working.
Innovator Funding
Up to £100,000 over two years (£50,000 per year)
- Investments into the testing and piloting of new approaches
- The proposed approach(es) must be new to the funding applicant but can have been delivered by another organisation in a different location or aimed at a different target population.
A two 2- year pilot that aims to build evidence before scale-up
Momentum Funding
- Up to £300,000 over three years (£ 100,000 per year)
- Advancing existing, evidence-based projects to enable sustainable scale-up
- The funding applicant must have delivered the approach(es) previously and have evidence that the approach(es) work
- Funding can be used to build on previous investments made by Positive Action or other donors
A three-year scale-up aimed at advancing previous projects with a focus on sustaining interventions beyond the three-year Positive Action investment
Funding Rounds
Closed Funding Round: New Funding Opportunity for Existing Positive Action Partners.
Positive Action has launched a closed call for the 2025 Momentum Prevention funding round. This round is open to existing Positive Action Community Strategic Initiatives grantees who are focused on scaling up evidence-based approaches for community-led combination HIV prevention targeting adolescents and young people aged 15-24 years.
Application window: 26 May 2025 – 18 June 2025
Applications accepted to support interventions in the following countries: Kenya, Malawi, Mozambique, Tanzania, South Africa, Uganda and Zambia.
Funding available: £300,000 over three years (£100,000 a year)
Proposals for Momentum grants should focus on the advancement of existing, evidence-based community-led interventions. Your project must focus on scaling up or replicating interventions that have proven to work. The scale-up can be based on lessons learned from a project implemented within/outside your organisation. It cannot be a pilot project.
Focus of the call: Positive Action welcomes proposals designed to provide community-led combination HIV prevention for adolescents and young people 15-24 years.
For this funding round we want applicants to focus on adolescent boys and young men (15-24) as primary population while acknowledging adolescent girls and young women as a secondary population.
We are looking for interventions that seek to address HIV prevention needs in adolescents and young people aged 15 to 24, focusing on adolescent boys and young men. Proposals can also integrate programming that reaches the secondary population of adolescent girls and young women, reflecting a relationship centred approach. While this is optional, all proposals should demonstrate an understanding of the broader HIV prevention context, including the interconnected needs of both groups.
It is important that adolescent boys and young men are involved in the design of the programme and are given the opportunity to advocate for themselves.
Click here to download a detailed guidance note in English. Please note, applications must be submitted in English.
Completing your application
Use this link to login to your profile and to complete your application through the CyberGrants Portal.
Please do not email applications to ViiV Healthcare or Positive Action staff members/Positive Action mailboxes. We will only accept applications via the online application system.
If you have any question or problems accessing the online system, please contact the Positive Action mailbox: pa.generalenquiries@viivhealthcare.com
NP-GBL-HVX-COCO-220063 | June 2025
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
